Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus

Taku Kikuchi; Takehiko Mori; Takayuki Shimizu; Yuya Koda; Ryohei Abe; Yuichi Kurihara; Takeru Funakoshi; Jun Yamagami; Hidekazu Sato; Kazuyuki Tsunoda; Masayuki Amagai; Shinichiro Okamoto

doi:10.1007/s00277-017-3008-8

Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus

Taku Kikuchi, Takehiko Mori, Takayuki Shimizu, Yuya Koda, Ryohei Abe, Yuichi Kurihara, Takeru Funakoshi, Jun Yamagami, Hidekazu Sato, Kazuyuki Tsunoda, Masayuki Amagai, Shinichiro Okamoto

Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	1221-1222
Number of pages	2
Journal	Annals of Hematology
Volume	96
Issue number	7
DOIs	https://doi.org/10.1007/s00277-017-3008-8
Publication status	Published - 2017 Jul 1

ASJC Scopus subject areas

Hematology

Access to Document

10.1007/s00277-017-3008-8

Cite this

Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus. / Kikuchi, Taku ; Mori, Takehiko ; Shimizu, Takayuki ; Koda, Yuya; Abe, Ryohei; Kurihara, Yuichi; Funakoshi, Takeru ; Yamagami, Jun; Sato, Hidekazu; Tsunoda, Kazuyuki ; Amagai, Masayuki; Okamoto, Shinichiro.

In: Annals of Hematology, Vol. 96, No. 7, 01.07.2017, p. 1221-1222.

Research output: Contribution to journal › Letter › peer-review

@article{6a838159ff8547a0852ab4c9c3e39405,

title = "Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus",

author = "Taku Kikuchi and Takehiko Mori and Takayuki Shimizu and Yuya Koda and Ryohei Abe and Yuichi Kurihara and Takeru Funakoshi and Jun Yamagami and Hidekazu Sato and Kazuyuki Tsunoda and Masayuki Amagai and Shinichiro Okamoto",

note = "Funding Information: Conflict of interest SO received research funding and honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd. TM received honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd. TF received research funding and honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd.",

year = "2017",

month = jul,

day = "1",

doi = "10.1007/s00277-017-3008-8",

language = "English",

volume = "96",

pages = "1221--1222",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer Verlag",

number = "7",

}

TY - JOUR

T1 - Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus

AU - Kikuchi, Taku

AU - Mori, Takehiko

AU - Shimizu, Takayuki

AU - Koda, Yuya

AU - Abe, Ryohei

AU - Kurihara, Yuichi

AU - Funakoshi, Takeru

AU - Yamagami, Jun

AU - Sato, Hidekazu

AU - Tsunoda, Kazuyuki

AU - Amagai, Masayuki

AU - Okamoto, Shinichiro

N1 - Funding Information: Conflict of interest SO received research funding and honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd. TM received honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd. TF received research funding and honoraria from Eisai Co. Ltd. and Chugai Pharmaceutical Co. Ltd.

PY - 2017/7/1

Y1 - 2017/7/1

UR - http://www.scopus.com/inward/record.url?scp=85018318015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018318015&partnerID=8YFLogxK

U2 - 10.1007/s00277-017-3008-8

DO - 10.1007/s00277-017-3008-8

M3 - Letter

C2 - 28447163

AN - SCOPUS:85018318015

VL - 96

SP - 1221

EP - 1222

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 7

ER -

Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this